Jiangsu Hengrui Medicine (600276.SS) - EPS (earnings per share)

EPS in 2026 (TTM): A$0.22

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is A$0.21. In 2025 the company made an earnings per share (EPS) of A$0.24 an increase over its 2024 EPS that were of A$0.19.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	A$0.22	-6.47%
2025	A$0.24	24.14%
2024	A$0.19	42.43%
2023	A$0.14	8.77%
2022	A$0.12	-20.62%
2021	A$0.16	-26.59%
2020	A$0.21	27.24%
2019	A$0.17	28.41%
2018	A$0.13	20.04%
2017	A$0.11	31.21%
2016	A$0.08279	11.46%
2015	A$0.07428	36.27%
2014	A$0.05451	19.77%
2013	A$0.04551	18.05%
2012	A$0.03855	23.9%
2011	A$0.03112	26.9%
2010	A$0.02452	12.37%
2009	A$0.02182	56.6%
2008	A$0.01393	9.18%
2007	A$0.01276	114.48%
2006	A$0.005951	64.83%
2005	A$0.003610	35.55%
2004	A$0.002663	29.73%
2003	A$0.002053	19.86%
2002	A$0.001713	-2.71%
2001	A$0.001761	1.02%
2000	A$0.001743

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Jiangsu Hengrui Medicine (600276.SS)